Evidence map›Paper›PMID 32226621›Full record

ReviewClinical liver disease2020

Treating Alcohol Use Disorder in Chronic Liver Disease.

Eric R Yoo, George Cholankeril, Aijaz Ahmed

Registry-linked trialOpen access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinical liver disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06471686 (Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06471686 phase2completednot on this mapstarted 2021, after this paper: background citation

Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations

TypeinterventionalSponsorUniversity of Southern CaliforniaRan2021 to 2023Enrolled30ConditionsAlcohol Use Disorder, Liver Transplant, ComplicationsArmsAcamprosate
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Eric R YooDepartment of Internal Medicine Santa Clara Valley Medical Center San Jose CA.ORCID https://orcid.org/0000-0002-0584-6975
George CholankerilDivision of Gastroenterology and Hepatology Stanford University School of Medicine Stanford CA.
Aijaz AhmedDivision of Gastroenterology and Hepatology Stanford University School of Medicine Stanford CA.
Stanford University · USSanta Clara Valley Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-2-reading-yoo a video presentation of this article http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-2-interview-yoo an interview with the author Answer questions and earn https://www.wileyhealthlearning.com/Activity/7036145/disclaimerspopup.aspx.

Identifiers

PMID32226621
PMCPMC7098671
OpenAlexW3013912703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.